Chronic myelogenous leukemia: disease biology and current and future therapeutic strategies

H Kantarjian, JV Melo, S Tura, S Giralt… - ASH Education …, 2000 - ashpublications.org
Over the last 2 decades, four major therapeutic approaches have drastically changed the
prognosis in chronic myelogenous leukemia (CML): 1) allogeneic stem cell transplant (SCT); …
被引用次数：76 相关文章
[PDF] psu.edu

[PDF][PDF] Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies

H Kantarjian, JV Melo, S Tura, S Giralt, M Talpaz - Hematology, 2000 - Citeseer
Over the last 2 decades, four major therapeutic approaches have drastically changed the
prognosis in chronic myelogenous leukemia (CML): 1) allogeneic stem cell transplant (SCT); …

Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies

H Kantarjian, JV Melo, S Tura… - … American Society of …, 2000 - pubmed.ncbi.nlm.nih.gov
Over the last 2 decades, four major therapeutic approaches have drastically changed the
prognosis in chronic myelogenous leukemia (CML): 1) allogeneic stem cell transplant (SCT); …
[PDF] archive.org

[PDF][PDF] Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies

H Kantarjian, JV Melo, S Tura, S Giralt, M Talpaz - Hematology, 2000 - scholar.archive.org
Over the last 2 decades, four major therapeutic approaches have drastically changed the
prognosis in chronic myelogenous leukemia (CML): 1) allogeneic stem cell transplant (SCT); …

Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies.

H Kantarjian, JV Melo, S Tura, S Giralt… - … . American Society of …, 2000 - europepmc.org
Over the last 2 decades, four major therapeutic approaches have drastically changed the
prognosis in chronic myelogenous leukemia (CML): 1) allogeneic stem cell transplant (SCT); …